Home

απλός Περιουσία Μπουμπούκι adapt des trial βλάκας Ανακριβής Ζηλωτής

Effect of Intravascular Ultrasound–Guided Drug-Eluting Stent Implantation:  5-Year Follow-Up of the IVUS-XPL Randomized Trial - ScienceDirect
Effect of Intravascular Ultrasound–Guided Drug-Eluting Stent Implantation: 5-Year Follow-Up of the IVUS-XPL Randomized Trial - ScienceDirect

Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From  ADAPT-DES - ScienceDirect
Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES - ScienceDirect

Intravascular Imaging Optical Coherence Tomography (OCT) Clinical Outcomes  | Abbott
Intravascular Imaging Optical Coherence Tomography (OCT) Clinical Outcomes | Abbott

Use of intravascular ultrasound and long-term cardiac death or myocardial  infarction in patients receiving current generation drug-eluting stents |  Scientific Reports
Use of intravascular ultrasound and long-term cardiac death or myocardial infarction in patients receiving current generation drug-eluting stents | Scientific Reports

Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI | NEJM
Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI | NEJM

Drug-Eluting Stents, Heart Attack and Bleeding Risks: One-Year Results of  ADAPT-DES Trial - HealthManagement.org
Drug-Eluting Stents, Heart Attack and Bleeding Risks: One-Year Results of ADAPT-DES Trial - HealthManagement.org

Platelet reactivity and clinical outcomes after coronary artery  implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre  registry study - The Lancet
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study - The Lancet

PDF) ADAPT-DES study
PDF) ADAPT-DES study

Frontiers | Antiplatelet Therapy for Atherothrombotic Disease in 2022—From  Population to Patient-Centered Approaches
Frontiers | Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches

KURZPROTOKOLL ADAPT
KURZPROTOKOLL ADAPT

Platelet reactivity and clinical outcomes after coronary artery  implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre  registry study - The Lancet
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study - The Lancet

Clinical Trial Phases Powerpoint Presentation Slides | Presentation  Graphics | Presentation PowerPoint Example | Slide Templates
Clinical Trial Phases Powerpoint Presentation Slides | Presentation Graphics | Presentation PowerPoint Example | Slide Templates

Afnic joins forces with Shopify to support French retailers in their  digital transition
Afnic joins forces with Shopify to support French retailers in their digital transition

ADAPT-DES Trial: 1 in 8 patients with PCI-DES have increased mortality
ADAPT-DES Trial: 1 in 8 patients with PCI-DES have increased mortality

ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with  Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational  Study. - ppt download
ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download

JCM | Free Full-Text | Escalation and De-Escalation of Antiplatelet Therapy  after Acute Coronary Syndrome or PCI: Available Evidence and Implications  for Practice
JCM | Free Full-Text | Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice

Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and  Platelet Reactivity: Analysis From ADAPT-DES | JACC: Cardiovascular  Interventions
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES | JACC: Cardiovascular Interventions

Temporal variability in the antiplatelet effects of clopidogrel and aspirin  after elective drug-eluting stent implantation
Temporal variability in the antiplatelet effects of clopidogrel and aspirin after elective drug-eluting stent implantation

Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a  Large All-Comers Registry | Circulation: Cardiovascular Interventions
Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry | Circulation: Cardiovascular Interventions

Improved 3-Year Cardiac Survival After IVUS–Guided Long DES Implantation: A  Patient-Level Analysis From 2 Randomized Trials - ScienceDirect
Improved 3-Year Cardiac Survival After IVUS–Guided Long DES Implantation: A Patient-Level Analysis From 2 Randomized Trials - ScienceDirect

ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with  Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational  Study. - ppt download
ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download

Bleeding Complications in Patients Undergoing Percutaneous Coronary  Intervention
Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention

Effects of genetic variants on platelet reactivity and one-year clinical  outcomes after percutaneous coronary intervention: A prospective  multicentre registry study | Scientific Reports
Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study | Scientific Reports

Sign up for a free Dynamics 365 Finance and operation trial – PARAG CHAPRE  BLOG
Sign up for a free Dynamics 365 Finance and operation trial – PARAG CHAPRE BLOG